THE TGA is seeking comments on
its proposed advisory statements
for fexofenadine and loperamide.
Proposed advisorary statements
for fexofenadine include: do not
use during pregnancy or
breastfeeding unless advised by
your doctor or pharmacist.
Proposed statements for loperamide
(when supplied as an OTC) include:
Do not give to children under 12
years; If the condition persists
after two days of treatment seek
medical advice; Do not use during
pregnancy or breastfeeding unless
advised by your doctor or
pharmacist; If you get an allergic
reaction stop taking and see your
doctor immediately; Drink plenty
of water; See your doctor or
pharmacist before taking this
product if you have a fever, severe
stomach pain, bloody diarrhoea or
ongoing medical condition
affecting the bowel; and Do not
take if you suffer a medical
condition where constipation
should be avoided.
See www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 07 May 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 12
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.